相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP
Rasmus Mogelvang et al.
HEART (2013)
Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients
Areti Augoulea et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Implication of receptor activator of NF-κB ligand in Wnt/β-catenin pathway promoting osteoblast-like cell differentiation
Bin Nie et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2012)
Inhibitory Role of Notch1 in Calcific Aortic Valve Disease
Asha Acharya et al.
PLOS ONE (2011)
Biomarkers of the Osteoprotegerin Pathway Clinical Correlates, Subclinical Disease, Incident Cardiovascular Disease, and Mortality
Wolfgang Lieb et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction
Hye-Lim Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Vascular Smooth Muscle Cell Stiffness As a Mechanism for Increased Aortic Stiffness With Aging
Hongyu Qiu et al.
CIRCULATION RESEARCH (2010)
Inflammation and the Osteogenic Regulation of Vascular Calcification A Review and Perspective
Jian-Su Shao et al.
HYPERTENSION (2010)
Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
Shreenidhi M. Venuraju et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
Anna Wasilewska et al.
PEDIATRIC NEPHROLOGY (2010)
Notch Signaling Induces Osteogenic Differentiation and Mineralization of Vascular Smooth Muscle Cells Role of Msx2 Gene Induction via Notch-RBP-Jk Signaling
Takehisa Shimizu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Notch1 represses osteogenic pathways in aortic valve cells
Vishal Nigam et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification
Mhairi K. Sigrist et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Notch and Vascular Smooth Muscle Cell Phenotype
David Morrow et al.
CIRCULATION RESEARCH (2008)
Notch signaling in cardiac development
Kyle Niessen et al.
CIRCULATION RESEARCH (2008)
The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review
Mads Nybo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes
Torbjorn Omland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort
U. Baber et al.
KIDNEY INTERNATIONAL (2008)
NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells
Shuting Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Role of osteoprotegerin in arterial calcification development of new animal model
Yuichi Orita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Long-term prognosis associated with coronary calcification - Observations from a registry of 25,253 patients
Matthew J. Budoff et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Serum levels of calcification inhibition proteins and coronary artery calcium score: Comparison between transplantation and dialysis
Sandro Mazzaferro et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Association between phosphate removal and markers of bone turnover in haemodialysis patients
Marta Albalate et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Enhanced T-cell expression of RANK ligand in acute coronary syndrome -: Possible role in plaque destabilization
WJ Sandberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Notch receptor encodes two structurally separable functions in Drosophila:: A genetic analysis
T Langdon et al.
DEVELOPMENTAL DYNAMICS (2006)
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE(-/-) mice
Brian J. Bennett et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification
V. P. Iyemere et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction
A Crisafulli et al.
CLINICAL SCIENCE (2005)
Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-κB signaling pathways
A Zampetaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Osteoprotegerin and diabetic macroangiopathy
T Ledet
HORMONE AND METABOLIC RESEARCH (2005)
Arterial osteoprotegerin:: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-α
P Olesen et al.
DIABETOLOGIA (2005)
Pathophysiology of vascular calcification in chronic kidney disease
SM Moe et al.
CIRCULATION RESEARCH (2004)
Atherosclerotic plaque smooth muscle cells have a distinct phenotype
ER Mulvihill et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
P Collin-Osdoby
CIRCULATION RESEARCH (2004)
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases
JJ Body et al.
CANCER (2003)
Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation
A Fahrleitner et al.
BONE (2003)
Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease
S Jono et al.
CIRCULATION (2002)
PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways
JF Zhang et al.
FEBS LETTERS (2002)
Activation of peroxisome proliferator-activated receptor γ inhibits osteoprotegerin gene expression in human aortic smooth muscle cefls
MG Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Osteoprotegerin levels before and after renal transplantation
T Sato et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D
PA Price et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease
RA O'Rourke et al.
CIRCULATION (2000)